ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,294, issued on April 7, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Methods to decrease impurities from recombinant prote... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,295, issued on April 7, was assigned to Prothena Biosciences Ltd. (Dublin) and Hoffmann-La Roche Inc. (Little Falls, N.Y.). "Dosing regimes... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,297, issued on April 7, was assigned to In3Bio Ltd. (Hamilton, Bermuda). "Methods and compositions for inhibition of EGF/EGFR pathway in co... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,298, issued on April 7, was assigned to XIYUAN ANJIAN MEDICINE (SHANGHAI) Co. LTD (Shanghai). "Anti-NGF antibody and antigen-binding fragme... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,299, issued on April 7, was assigned to Chugai Seiyaku K.K. (Tokyo). "FC variants" was invented by Tomoyuki Igawa (Shizuoka, Japan), Atsuhi... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,300, issued on April 7, was assigned to Akeso Biopharma Inc. (Zhongshan, China). "Anti-human P40 protein domain antibody and use thereof" w... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,301, issued on April 7, was assigned to Pfizer Inc. (New York), The Regents of the University of California (Oakland, Calif.) and The Board ... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,302, issued on April 7, was assigned to SANYOU BIOPHARMACEUTICALS Co. LTD. (Shanghai). "CLDN18.2 binding molecule" was invented by Yongcong... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,303, issued on April 7, was assigned to The General Hospital Corp. (Boston). "Antibodies and chimeric antigen receptors that target TACI" w... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,304, issued on April 7, was assigned to STCube & Co. Inc. (Seoul, South Korea). "Antibodies specific to glycosylated LAG3 and methods of us... Read More